Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

To move beyond a select few genes/drugs, the successful adoption of pharmacogenomics into routine clinical care requires a curated and machine-readable database of pharmacogenomic knowledge suitable for use in an electronic health record (EHR) with clinical decision support (CDS). Recognizing that EHR vendors do not yet provide a standard set of CDS functions for pharmacogenetics, the Clinical Pharmacogenetics Implementation Consortium (CPIC) Informatics Working Group is developing and systematically incorporating a set of EHR-agnostic implementation resources into all CPIC guidelines. These resources illustrate how to integrate pharmacogenomic test results in clinical information systems with CDS to facilitate the use of patient genomic data at the point of care. Based on our collective experience creating existing CPIC resources and implementing pharmacogenomics at our practice sites, we outline principles to define the key features of future knowledge bases and discuss the importance of these knowledge resources for pharmacogenomics and ultimately precision medicine.

[1]  Pedro J. Caraballo,et al.  Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus , 2012, J. Am. Medical Informatics Assoc..

[2]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[3]  Heidi L Rehm,et al.  ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.

[4]  Marc S. Williams,et al.  Integration of Genomics into the Electronic Health Record: Mapping Terra Incognita , 2013, Genetics in Medicine.

[5]  Christopher G. Chute,et al.  CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record , 2015, J. Am. Medical Informatics Assoc..

[6]  Christopher G Chute,et al.  Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. , 2014, Mayo Clinic proceedings.

[7]  L Gong,et al.  The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update , 2014, Clinical pharmacology and therapeutics.

[8]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[9]  M R Wilkinson,et al.  A Clinician‐Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record , 2012, Clinical pharmacology and therapeutics.

[10]  K. Sangkuhl,et al.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors , 2015, Clinical pharmacology and therapeutics.

[11]  Dan M. Roden,et al.  Leveraging the electronic health record to implement genomic medicine , 2012, Genetics in Medicine.

[12]  Kensaku Kawamoto,et al.  Characterizing genetic variants for clinical action , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[13]  Marc S. Williams,et al.  Genomic medicine implementation: Learning by example , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[14]  Russ B Altman,et al.  PharmGKB: the Pharmacogenomics Knowledge Base. , 2013, Methods in molecular biology.

[15]  T E Klein,et al.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing , 2014 .

[16]  Isaac S. Kohane,et al.  Technical desiderata for the integration of genomic data into Electronic Health Records , 2012, J. Biomed. Informatics.

[17]  Suzette J. Bielinski,et al.  Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems , 2014, Clinical pharmacology and therapeutics.

[18]  Gilad J. Kuperman,et al.  Editorial Comments: Using Commercial Knowledge Bases for Clinical Decision Support: Opportunities, Hurdles, and Recommendations , 2006, J. Am. Medical Informatics Assoc..

[19]  Julia M. Barbarino,et al.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing , 2015, Clinical pharmacology and therapeutics.

[20]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[21]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[22]  Kevin B. Johnson,et al.  Electronic health record design and implementation for pharmacogenomics: a local perspective , 2013, Genetics in Medicine.

[23]  E. Clayton,et al.  Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project , 2012, Clinical pharmacology and therapeutics.

[24]  Teri E. Klein,et al.  Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process , 2014, Current drug metabolism.

[25]  Lisa P. Newmark,et al.  A novel clinician interface to improve clinician access to up-to-date genetic results. , 2014, Journal of the American Medical Informatics Association : JAMIA.

[26]  Erica A. Bowton,et al.  Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing , 2013, Clinical pharmacology and therapeutics.

[27]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[28]  D. Longo,et al.  Precision medicine--personalized, problematic, and promising. , 2015, The New England journal of medicine.

[29]  Guilherme Del Fiol,et al.  Technical desiderata for the integration of genomic data with clinical decision support , 2014, J. Biomed. Informatics.

[30]  Thomas H. Payne,et al.  Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs , 2015, J. Am. Medical Informatics Assoc..

[31]  M. Relling,et al.  Development and use of active clinical decision support for preemptive pharmacogenomics , 2013, Journal of the American Medical Informatics Association : JAMIA.

[32]  Jon W. McKeeby,et al.  Integrating pharmacogenetic information and clinical decision support into the electronic health record , 2014, J. Am. Medical Informatics Assoc..

[33]  Ching-Hon Pui,et al.  PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[34]  Mark A. Hoffman,et al.  Electronic medical records and personalized medicine , 2011, Human Genetics.

[35]  Eneida A. Mendonça,et al.  Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations , 2013, J. Am. Medical Informatics Assoc..

[36]  Teri E Klein,et al.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. , 2015, Annual review of pharmacology and toxicology.

[37]  Kristin A. Maloney,et al.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real‐World Implementation , 2013, Clinical pharmacology and therapeutics.

[38]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[39]  Justin Starren,et al.  Crossing the omic chasm: a time for omic ancillary systems. , 2013, JAMA.

[40]  T. Klein,et al.  Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing: 2014 Update , 2014, Clinical pharmacology and therapeutics.

[41]  Christopher G Chute,et al.  Genomic medicine, health information technology, and patient care. , 2013, JAMA.

[42]  S. Haga,et al.  Integrating pharmacogenetic testing into primary care , 2017, Expert review of precision medicine and drug development.